News Releases

Mar 27, 2020
Fernando J. Sallés, Ph.D., CLP ® , Appointed to Lead I-Mab’s U.S. and EU Business Development SHANGHAI, China and ROCKVILLE, MD., March 27, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and
Feb 25, 2020
SHANGHAI, China and ROCKVILLE, MD., Feb. 25, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet
Jan 17, 2020
- ADSs to Begin Trading on Nasdaq on January 17, 2020 - SHANGHAI, China and ROCKVILLE, Md., Jan. 17, 2020 (GLOBE NEWSWIRE) -- I-Mab (“I-Mab” or the “Company”) (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly
Displaying 31 - 37 of 37